to page content
to site navigation
Steve Blank is a retired serial entrepreneur with over 30 years of experience in high technology companies and management. He is a Consulting Professor at Stanford in the Graduate School of Engineering STVP Program.
Steve has been a founder or participant in eight Silicon Valley startups since 1978. His last company, E.piphany, started in his living room. His other startups include two semiconductor companies (Zilog and MIPS Computers), a workstation
company (Convergent Technologies), a supercomputer firm (Ardent), a computer peripheral supplier (SuperMac), a military intelligence systems supplier (ESL) and a video game company (Rocket Science Games). Steve is on the board of
CafePress.com, an on-line marketplace, and IMVU, a 3D IM social network. Steve was appointed by Governor Arnold Schwarzenegger to the California Coastal Commission and is the Chairman of Audubon California and on the board of the Peninsula
Open Space Trust (POST.) His Google Tech talk, "The Secret History of Silicon Valley" (available on YouTube) is one of the definitive views on the early history of innovation in Silicon Valley. Steve teaches entrepreneurship and a
methodology of managing marketing, sales and business development in high technology startups. His course text "Four Steps to the Epiphany" is the definitive work on Customer Development and is one of the foundations of Lean
Jeff Hawkins is the Founder of Numenta, but he is also well known as the co-founder of two companies, Palm and Handspring, and as the architect of many computing products, such as the PalmPilot and the Treo smartphone.
Throughout his life Hawkins has also had a deep interest in neuroscience and theories of the neocortex. His interest in the brain led him to create the non-profit Redwood Neuroscience Institute (RNI), a scientific organization focused on
understanding how the human neocortex processes information. While at RNI, Hawkins developed a theory of neocortex which appeared in his 2004 book, On Intelligence. Along with Dileep George and Donna Dubinsky, Hawkins
founded Numenta in 2005 to develop a technology platform derived from his theory. It is his hope that Numenta will play a catalytic role in creating an industry based on this theory and technology. Jeff Hawkins earned his B.S. in
electrical engineering from Cornell University in 1979. He was elected to the National Academy of Engineering in 2003.
As the president of Yahoo! Inc., Susan L. Decker is a key participant in determining Yahoo!'s business strategy and vision. She is responsible for all of the global business operations of Yahoo!, including sales, product
marketing, and distribution across the three major customer groups of audience, advertisers, and publishers. Prior to that, from December 2006 - June 2007, she served as the head of one of Yahoo!'s two major business units, the Advertiser
and Publisher Group (APG). In that role, she was instrumental in developing the company's recent reorganization plan and strategy to transform how advertisers connect with their target customers online. Preceding her work with APG, Decker
was Executive Vice President and Chief Financial Officer for seven years, managing all aspects of the company's financial and administrative direction within key functional areas, including finance, facilities, investor relations (and
human resources and legal through December 2006). Decker served on the board of directors of Pixar Animation Studios from June 2004 to May 2006 until its sale to Disney, and currently serves on the board of directors for Berkshire
Hathaway, Intel Corporation, and Costco Wholesale. She holds a Bachelor of Science degree from Tufts University, with a double major in computer science and economics, and an MBA from Harvard Business School.
Dr. Larry Brilliant is the Executive Director of Google.org, where he leads major initiatives aimed at reducing global poverty, improving the health of the least advantaged in the world, and working to halt the effects
of the climate crisis. Larry is an M.D. and M.P.H., board-certified in preventive medicine and public health. He is a founder and director of The Seva Foundation, which works in dozens of countries around the world, primarily to eliminate
preventable and curable blindness. He serves as a member of the strategic advisory committee for Kleiner Perkins (KPCB) Venture Capital and also sits on the boards of The Skoll Foundation, Health Metrics Network, Omidyar Networks Humanity
United, and InSTEDD, an organization bringing technological tools to improve disaster response. In addition to his medical career, Larry co-founded The Well, a pioneering virtual community, with Stewart Brand in 1985. He also holds a
telecommunications technology patent and has served as CEO of two public companies and other venture-backed start-ups. The author of two books and dozens of articles on infectious diseases, blindness, and international health policy, Larry
has worked at every level of government. He was recently a "first responder" for CDC's smallpox bio-terrorism response effort, volunteered in Sri Lanka for tsunami relief, and established an interdisciplinary consultancy to prepare for
possible pandemic influenza. Larry lived in India working as a United Nations medical officer for more than a decade where he played a key role in the successful World Health Organization (WHO) smallpox eradication program and has recently
worked for the WHO polio eradication effort as well. He was Associate Professor of epidemiology, global health planning and economic development at the University of Michigan. Larry earned a Masters in Public Health in health planning and
economic development from the Univ
John G. Melo is the Chief Executive Officer of Amyris Biotechnologies, a synthetic biology company working to reduce the cost of curing malaria and producing lower carbon, second generation bio-fuels. He was previously
president of U.S. Fuels for BP, where he led one of the world's largest petroleum marketing, logistics, and trading businesses. While in this role he successfully grew revenues from $25 billion to $34 billion and increased net cash by $1
billion. During this time his team developed one of the world's most successful ethanol blending and marketing businesses. He also worked on the development of BP's "Helios" re-branding. Prior to his eight years with BP, Mr. Melo was a
director with Ernst & Young in San Jose, California, and a management team member for several Northern California start-ups, including Computer Aided Services and Alldata Corporation. John serves on the Board of Directors for U.S. Oil,
a $1.6 billion energy company, and Cilion, a leading low-cost ethanol manufacturer. John is a member of the Economic Club of Chicago, The Chicago Club, The Chicago Council on Global Affairs, and YPO. He enjoys visiting his home country of
Azores, Portugal, as well as skiing, biking, tennis, golf, and time with his children.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Frank H. Levinson founded Finisar in April 1987 and has served as a member of our Board of Directors since February 1988 and as our Chairman of the Board and Chief Technical Officer since August 1999. Mr. Levinson also
served as our Chief Executive Officer from February 1988 to August 1999. From September 1980 to December 1983, Mr. Levinson was a Member of Technical Staff at AT&T Bell Laboratories. From January 1984 to July 1984, he was a Member of
Technical Staff at Bellcore, a provider of services and products to the communications industry. From April 1985 to December 1985, Mr. Levinson was the principal optical scientist at Raychem Corporation, and from January 1986 to February
1988, he was Optical Department Manager at Raynet, Inc., a fiber optic systems company. Mr. Levinson holds a B.S. in Mathematics/Physics from Butler University and an M.S. and Ph.D. in Astronomy from the University of
David M. Kelley is a California-based entrepreneur, educator, engineer, and venture capitalist. He was featured by Fortune magazine as one of the "People to Watch" and was selected for the "I.D. 40" list of America's
leading design innovators. In that listing he was described as "the most sought-after design engineer this side of Thomas Edison." He is the founder and CEO of IDEO Product Development, America's largest independent product design and
development firm. In addition to his work at IDEO Product Development, Kelley is a tenured professor at Stanford University in the school's innovative Product Design program. As a faculty member, Professor Kelley is interested in new
product development methodology from inception to production with an emphasis on user-centered design. He encourages broad understanding of product design methodologies, exposing his students to a variety of viewpoints in classroom
discussions and project work. Professor Kelley's primary involvement is in the product design program, a joint program with the art department which emphasizes the blending of innovation, human values, and aesthetic concerns into a single
curriculum. He also teaches in the Human Computer Interface program, which is a joint program with computer science.
Google founders Larry Page and Sergey Brin recruited Eric Schmidt from Novell, where he led that company's strategic planning, management and technology development as chairman and CEO. Since coming to Google, Schmidt
has focused on building the corporate infrastructure needed to maintain Google's rapid growth as a company and on ensuring that quality remains high while product development cycle times are kept to a minimum. Along with Page and Brin,
Schmidt shares responsibility for Google's day-to-day operations. Schmidt's Novell experience culminated a 20-year record of achievement as an Internet strategist, entrepreneur and developer of great technologies. Schmidt's well-seasoned
perspective perfectly complements Google's needs as a young and rapidly growing search engine with a unique corporate culture. Prior to his appointment at Novell, Schmidt was chief technology officer and corporate executive officer at Sun
Microsystems, Inc., where he led the development of Java, Sun's platform-independent programming technology, and defined Sun's Internet software strategy. Before joining Sun in 1983, Schmidt was a member of the research staff at the
Computer Science Lab at Xerox Palo Alto Research Center (PARC), and held positions at Bell Laboratories and Zilog. Schmidt has a bachelor of science degree in electrical engineering from Princeton University, and a master's and Ph.D. in
computer science from the University of California-Berkeley.
Paul G. Yock, M.D. is the Martha Meier Weiland Professor of Medicine and Professor of Mechanical Engineering, by courtesy. Dr. Yock is Co-Chair of Stanford's new Department of Bioengineering and Director of the Stanford
Program in Biodesign. Dr. Yock is a Stanford cardiologist internationally known for his work in inventing, developing and testing new devices, including the Rapid Exchange balloon angioplasty system, which is the dominant angioplasty
system in use worldwide. Yock also invented a Doppler-guided hypodermic needle system, the Smart Needle and P-D Access. Dr. Yock is Director of the Center for Research in Cardiovascular Interventions, a Stanford facility that develops and
tests new technologies in cardiovascular medicine. The focus of Dr. Yock's research program is the field of intravascular ultrasound. He authored the fundamental patents for intravascular ultrasound imaging and founded Cardiovascular
Imaging Systems, now a division of Boston Scientific resulting from a 1994 acquisition for over $100M. In 1998 Dr. Yock developed a new interdepartmental and inter-school program at Stanford, the Medical Device Network (MDN). MDN helps
stimulate and guide the process of biomedical technology innovation within the University. Recently MDN has been expanded under Dr. Yock's leadership into a broader research and educational initiative, the Stanford Program in Biodesign.
MDN is now BDN, the Biodesign Network. The primary mission of Biodesign is to promote the invention and implementation of new health technologies through interdisciplinary research and education at the frontiers of engineering and the
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.